ORPHA:1915
Fetal alcohol syndrome
Also known as: ARND · Alcohol-related birth defects · Alcohol-related neurodevelopmental disorder · FAS · FASD · Fetal alcohol spectrum disorders · ARBD
Publications
11,500
Trials
50
Interventional, condition-specific
Researchers
968
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
Fetal alcohol syndrome (FAS) is a rare syndrome caused by excessive maternal consumption of alcohol during pregnancy. It is characterized by and/or postnatal growth deficiency (weight and/or height <10th percentile), a unique cluster of minor facial anomalies (short palpebral fissures, flat and smooth philtrum, and thin upper lip) and severe central nervous system (CNS) abnormalities including microcephaly, and cognitive and behavioral impairment (, deficit in general cognition, learning and language, executive function, visual-spatial processing, memory, and attention).
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0016011
- UMLS:C0015923
- NCIT:C84713
Additional Mondo synonyms (1)
alcohol-related neurodevelopmental disorder
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
11,500 matched papers (4,321 in last 10 years) Source
- Phenotype characterisedPresent
32 HPO annotations (e.g. Intrauterine growth retardation; Short stature; Cognitive impairment) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
50 matched on ClinicalTrials.gov (13 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
32
Associated phenotypes · MONDO:0016011
- Intrauterine growth retardation
- Short stature
- Cognitive impairment
- Thin upper lip vermilion
- Microdontia
Showing 5 of 32 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
11,500
11,500 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
11,500 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
4,321 in the last 10 years · low confidence
Phrase hits: 11,500 · MeSH hits: 0
Who's working on it?
968
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01
- 02Kalberg WO10 papers · 2026
Center on Alcohol, Substance Use and Addictions (CASAA), The University of New Mexico, Albuquerque, New Mexico, USA.
Papers in Europe PMC - 03May PA10 papers · 2026
Department of Nutrition, Gillings School of Global Public Health, Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, North Carolina, USA.
Papers in Europe PMC - 04Wozniak JR10 papers · 2026
Department of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, USA.
Papers in Europe PMC - 05Buckley D9 papers · 2026
Center on Alcohol, Substance Use and Addictions (CASAA), The University of New Mexico, Albuquerque, New Mexico, USA.
Papers in Europe PMC - 06Hasken JM8 papers · 2026
Department of Nutrition, Gillings School of Global Public Health, Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, North Carolina, USA.
Papers in Europe PMC - 07Marais AS8 papers · 2026
Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
Papers in Europe PMC - 08Robinson LK8 papers · 2026
Dysmorphology and Clinical Genetics, State University of New York at Buffalo, Buffalo, New York, USA.
Papers in Europe PMC - 09Seedat S8 papers · 2026
Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
Papers in Europe PMC - 10Abdul-Rahman O7 papers · 2026
Department of Pediatrics, New York- Presbyterian Weill Cornell Medicine, Columbia University, New York, New York, USA.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
50
interventional trials for this specific condition
50 interventional trials matched this specific condition name; 13 currently recruiting in our sample.
Data as of 11 September 2026
50 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 97.1th percentile).
low confidence · 97.1th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
50 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07016009·RECRUITING·Thrive Person-Centered Planning Program for Young Adults With Fetal Alcohol Spectrum Disorders
Not reviewed·Conditions: Fetal Alcohol Spectrum Disorders·Matched via name phrase
- NCT06847165·RECRUITING·Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
Not reviewed·Conditions: Fetal Alcohol Spectrum Disorders · Attention Deficit Hyperactivity Disorder·Matched via name phrase
- NCT06005181·RECRUITING·The Synchrony Study: Examining Music Training for Children With FASD
Not reviewed·Conditions: Fetal Alcohol Spectrum Disorders·Matched via name phrase
- NCT05456321·RECRUITING·CIFASD 5 tDCS and Cognitive Training
Not reviewed·Conditions: Fetal Alcohol Spectrum Disorders·Matched via name phrase
- NCT05960461·RECRUITING·Families Moving Forward (FMF) Connect Pro for Mental Health Providers
Not reviewed·Conditions: Fetal Alcohol Spectrum Disorders·Matched via name phrase
- NCT06638463·RECRUITING·My Health Coach App RCT
Not reviewed·Conditions: Fetal Alcohol Spectrum Disorders·Matched via name phrase
- NCT05686473·RECRUITING·Psychoeducation of Parents to Children With FASD
Not reviewed·Conditions: Fetal Alcohol Spectrum Disorders · Behavior Problem · Adaptive Behavior · Learning Disorders·Matched via name phrase
- NCT03371641·RECRUITING·In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions
Not reviewed·Conditions: Fetal Alcohol Syndrome·Matched via name phrase
- NCT06635746·NOT YET RECRUITING·Dose Escalation Study of Vinpocetine in Healthy Volunteers
Not reviewed·Conditions: Fetal Alcohol Spectrum Disorders·Matched via name phrase
- NCT06935461·ENROLLING BY INVITATION·Families Moving Forward Bridges: An Early Intervention for Infants and Toddlers With PAE With or At-risk for FASD
Not reviewed·Conditions: Prenatal Alcohol Exposure · Fetal Alcohol Spectrum Disorders·Matched via name phrase
- NCT07547696·RECRUITING·CARRII Native Intervention Optimization Trial
Not reviewed·Conditions: Fetal Alcohol Spectrum Disorders · Pregnancy · Alcohol-Related Disorders · Drinking, Alcohol·Matched via name phrase
- NCT04395196·RECRUITING·RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure
Not reviewed·Conditions: Fetal Alcohol Spectrum Disorders · Fetal Alcohol Syndrome·Matched via name phrase
- NCT05534568·RECRUITING·The Oklahoma Parent-Child Assistance Program
Not reviewed·Conditions: Substance Use Disorders · Pregnancy Related · Alcohol Use Disorder (AUD) · Alcohol Use Complicating Pregnancy, First Trimester·Matched via name phrase
Observational and natural-history studies
6 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 10 · after dedupe 10 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 10 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (10)
- isrctn·ISRCTN36032472·No longer recruiting·Evaluation of the safety of ovarian support cell in vitro maturation (OSC-IVM) application during in vitro fertilization procedures for infertility treatment
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN45319897·No longer recruiting·A study to evaluate the safety, tolerability, processing by the body, and antitumor activity of inavolisib and paclitaxel
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN83755370·No longer recruiting·Health and physical activity among children with intellectual disabilities
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN82984919·No longer recruiting·A feasibility study investigating pravastatin for the prevention of preterm birth in women
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN29534081·No longer recruiting·Effects of a school-based intervention programme on growth, health and well-being of schoolchildren in three African countries: The KaziAfya project
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10055429·No longer recruiting·Can 3D photography at birth help to detect prenatal alcohol exposure?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17744284·No longer recruiting·Do brief mindfulness training and attention training games improve self control in 6-10 year-old children adopted internationally?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17787139·Stopped·Randomised trial of pravastatin versus placebo for the prevention of high blood pressure in pregnancy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN01253916·No longer recruiting·Antiepileptic drug monitoring In pregnancy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN75323409·No longer recruiting·The Maternal Obesity Management (MOM) Trial: lifestyle intervention during pregnancy to minimize downstream obesity in mother and child - a Pilot Study
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Fetal alcohol syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Fetal alcohol syndrome" OR "Alcohol-related birth defects" OR "Alcohol-related neurodevelopmental disorder" OR "Fetal alcohol spectrum disorders"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Fetal alcohol syndrome" OR "Alcohol-related birth defects" OR "Alcohol-related neurodevelopmental disorder" OR "Fetal alcohol spectrum disorders"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 50 interventional · 6 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: ARND; FAS; FASD; ARBD
Confidence reasoning
- Preferred label is multi-word and distinctive
- 4 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (11500) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-26T18:29:41.810Z
